Gandouling Inhibits the Sinusoid Capillarization Associated with Liver Fibrosis in Wilson’s Disease by Blocking the Communication Between Hepatic Stellate Cells and Liver Sinusoidal Endothelial Cells
<b>Background</b>: Gandouling (GDL) is a compound prepared in Chinese medicine and demonstrates favorable clinical efficacy. Studies have shown that sinusoid capillarization promoted hepatic fibrosis and was a potential target for preventing and treating liver fibrosis in Wilson's disease (WD). This study aimed to explore whether GDL inhibited the sinusoid capillarization in WD by blocking the communication between hepatic stellate cells (HSCs) and liver sinusoidal endothelial cells (LSECs). <b>Methods</b>: In this study, Atp7b-H1071Q (TX) mice were used as the WD model mice, and CuSO<sub>4</sub>⋅5H<sub>2</sub>O treated LX-2 cells were used as the HSC activation model. We used scanning electron microscopy, vascular tube formation assay, Western blot, cell transfection, and co-culture system to study how GDL blocked the communication between HSCs and LSECs, as well as its inhibitory effect on the sinusoid capillarization. <b>Results</b>: We found that GDL alleviated liver fibrosis in TX mice, inhibited HSC activation, and sinusoid capillarization in TX mice. Excessive secreted VEGFA by LX-2 cells promoted the sinusoid capillarization, played the role of a messenger molecule, and GDL blocked the VEGFA-mediated HSCs-LSECs communication. Furthermore, bioinformatics analysis, molecular docking, and molecular dynamics suggested that GDL may exert its effect by modulating the PDGFRβ/ERK/VEGFA signaling axis. We validated the above observation through experiments, that GDL reduced PDGFRβ/ERK signal pathway in LX-2 cells, inhibited the expression of messenger molecule VEGFA, blocked HSCs-LSECs communication, inhibited sinusoid capillarization, and improved WD. <b>Conclusions</b>: GDL blocked the communication between HSCs and LSECs and inhibited the sinusoid capillarization associated with liver fibrosis in WD by the PDGFRβ/ERK/VEGFA signaling axis.
Authors
- Peng Wu (ORCID: https://orcid.org/0000-0001-6565-0002)
- Yikang Cai (ORCID: https://orcid.org/0000-0003-4201-2790)
- Bing Wang (ORCID: https://orcid.org/0000-0003-0684-2789)
- Chenggui Miao
- Meiling Yuan
- Yingqiu Song
- Yajie Wu
- Qiying Jin
- Xinyue Zhou
Institutions
- Chinese University of Hong Kong (HK)
- Anhui University of Traditional Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
- University of Hong Kong (HK)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-01-25
- DOI
- https://doi.org/10.3390/ph19020203
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00